Patent · US Active

Pathway integration and expression in host cells

US11674145B2 · kind B2 · utility

0Cited by
0References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 24, 2017
Grant dateJun 13, 2023
Priority date
Expiry dateJan 18, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12R2001/425
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein are methods for integrating a gene of interest into a chromosome of a host cell. In some embodiments, the methods include introducing into a host cell a first plasmid comprising a transposase coding sequence and a donor sequence, which includes a selectable marker coding sequence flanked by a first and a second lox site and is itself flanked by inverted repeats recognized by the transposase. Following transposase-mediated chromosomal integration of the donor sequence into the host cell, a second plasmid is introduced, which comprises the gene of interest and a second selectable marker coding sequence, both flanked by a first and a second lox site. The gene of interest is chromosomally integrated into the host cell by recombinase-mediated cassette exchange (RMCE) between the donor sequence and the second plasmid via Cre-/cuc recombination. Further provided herein are host cells, vectors, and methods of producing a product related thereto.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.